The FDA panel voted against Otsuka's PTSD drug combination with Zoloft, questioning its efficacy. Getinge surpassed profit ...

This summary covers significant health news including FDA advisers rejecting Otsuka's PTSD treatment, Getinge exceeding ...

Humana losing star ratings is a big set-back that lead to its share price falling by 7.5% before paring losses.

Humana Inc. shares fell after it lost a lawsuit seeking to reverse cuts to its Medicare bonus payments, a blow for the insurer that had hoped the court would restore billions in revenue.

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Shares of Humana Inc. (NYSE: HUM) are trading lower Friday after the company lost a legal battle over Medicare bonus payments ...

Offering a rare glimpse inside the hidden world of rejected insurance claims, new data shows a steady uptick among major ...

A federal judge has tossed out a lawsuit from Humana that attempted to reinstate higher quality ratings to its 2025 Medicare ...

The company's stock has fallen sharply since it announced the Medicare ratings downgrade. On Oct. 1, the stock opened at $315. After the ruling Friday, the company's stock was down 2% to $219.04.

A federal judge in Texas on Friday tossed a lawsuit brought by Humana that challenged the U.S. government's reduction in the ...

Shares of health insurance company Humana (NYSE:HUM) fell 3.2% in the morning session after the company lost a lawsuit ...

It’s a stunning loss for the insurer, which sued the government late last year after its star ratings plummeted for 2025.